Pfizer-BioNTech/Comirnaty COVID-19 Vaccine Singapore

What Is the Pfizer-BioNTech/Comirnaty COVID-19 Vaccine?

The Pfizer-BioNTech/Comirnaty JN.1 COVID-19 vaccine is an mRNA-based formulation specifically updated to target variants of the SARS-CoV-2 virus, including the Omicron JN.1 strain.

It works by delivering messenger RNA (mRNA) that instructs the body's cells to create a harmless version of the virus's spike protein. This stimulates the immune system to recognise and respond to the virus if encountered in the future.

Unlike traditional protein-based vaccines, this mRNA vaccine contains no live virus and cannot transmit COVID-19.

Eligibility for Pfizer-BioNTech/Comirnaty JN.1 COVID-19 Vaccine

Approved in Singapore in October 2024, the Comirnaty JN.1 vaccine is part of the Ministry of Health's (MOH) National Vaccination Programme. It is available for individuals aged 12 and above who are eligible for mRNA-based vaccines.

Vaccination is encouraged for:

• Seniors aged 60 years and older
• Persons aged 6 months and above with underlying health conditions
• Those working or living in settings with elevated exposure risk, such as healthcare facilities

The vaccine is also suitable for those looking to stay up to date with the latest vaccine version targeting current virus variants.

Rare But Serious Reactions to Watch For

Although uncommon, some individuals may experience severe allergic responses. Symptoms to look out for include:

• Swelling of the face or eyes
• Difficulty breathing
• Generalised itchy rash

Seek immediate medical attention if any of these signs occur after vaccination.

Disclaimer: The side effects listed are not comprehensive. This information is not meant to replace professional medical advice. If you have concerns about vaccination or need more detailed guidance, please consult a doctor or refer to the MOH's FAQ page on COVID-19 vaccines.

Pfizer-BioNTech/Comirnaty JN.1 COVID-19 Vaccine Cost in Singapore

Under the Ministry of Health's National Vaccination Programme, the Pfizer-BioNTech/Comirnaty JN.1 vaccine is provided at no cost to Singapore Citizens, Permanent Residents, Long-Term Pass Holders, and eligible Short-Term Pass Holders.